Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-07-02Clinical Trial Update: Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder [Phase 2]
Phase 2 trial comparing citalopram alone to citalopram plus pindolol in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression [Phase 4]
Phase 4 clinical trial update evaluating antidepressant treatment and its effects on possible endo-phenotypes in major depressive disorder; …
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of Depression [Phase 3]
Phase 3 trial evaluating pulsed electromagnetic field therapy for treatment-resistant major depression completed; no efficacy results are pr…
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: A Study of Aripiprazole in Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating aripiprazole in major depressive disorder has completed and its results were posted.
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin [Phase 3]
A Phase 3 trial assessed whether paroxetine can prevent depressive syndrome in patients with chronic hepatitis C treated with pegylated inte…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Lamotrigine Augmentation in Resistant Depression [NA]
A completed clinical trial evaluated lamotrigine augmentation in treatment-resistant major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-04-13Clinical Trial Update: An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder [Phase 2]
A Phase 2 study evaluating two doses of SSR149415 in outpatients with major depressive disorder has completed, summarizing the efficacy and …
-
CLINICAL_TRIALS trial_result · 2009-04-02Clinical Trial Update: Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression [NA]
A completed clinical trial evaluated the efficacy and tolerability of combining aripiprazole with SSRIs for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine [Phase 3]
Phase 3 randomized trial assessing the efficacy and safety of a single dose of SR58611 compared with placebo and paroxetine in major depress…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of quetiapine fumarate (SEROQUEL) versus placebo and an active control in adults…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS) [Phase 3]
Phase 3 trial update reports on efficacy and safety of SR58611A in adults with major depressive disorder (SIRIUS).
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating the efficacy and safety of SR58611A co-administered with escitalopram in adults with major depressive disorder. The…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders [Phase 3]
Phase 3 trial update reporting the efficacy and safety of quetiapine fumarate sustained release (SEROQUEL SR) for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine [Phase 3]
Phase 3 trial investigating the efficacy and safety of SR58611 versus placebo and paroxetine in major depressive disorder; the document prov…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder [Phase 2]
Phase 2 trial examining the efficacy of SEROQUEL (quetiapine) as an adjunct to SSRI therapy in patients with SSRI-resistant major depressive…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder [Phase 3]
Phase 3 randomized, placebo-controlled trial assessing the safety and efficacy of quetiapine fumarate (SEROQUEL) versus placebo in adults wi…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of adding quetiapine fumarate sustained-release (SEROQUEL SR) to antidepressant therapy f…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder [Phase 3]
The document reports long-term safety and tolerability results from a Phase 3 trial of SR58611 in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder [Phase 3]
Phase 3 trial evaluating quetiapine fumarate as monotherapy for maintenance treatment in adults with major depressive disorder has completed…
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan [Phase 2]
Phase 2 trial of bupropion sustained-release in Japanese patients with major depressive disorder completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-03-17Clinical Trial Update: A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality [Phase 3]
A Phase 3 double-blind trial tests buprenorphine for acute suicidality in depressed patients; the current study status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response [NA]
A completed clinical trial study investigating how the menstrual cycle affects depressive symptoms and treatment response in individuals wit…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of SR58611A for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of SR58611A in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating SR58611A for relapse prevention in adults with major depressive disorder has completed.